Johnson & Johnson’s Stelara, Regeneron’s Eylea and Amgen’s Prolia are just some of the drugs facing off against new ...

The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...

On March 13, 2025, the U.S. Court of Appeals for the Federal Circuit affirmed a five-year patent term extension (“PTE”) for ...

The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...

The first time Dr. Fajgenbaum repurposed a drug, it was in an attempt to save his own life. At 25, while in medical school, ...

Pharmaceutical company Novartis is laying off more than 400 employees at its East Hanover facility as part of a restructuring ...

On March 13, 2025, the Federal Circuit decided in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. (No. 2023-2254) how ...

UnitedHealth Group Inc.’s drug-benefits unit is starting to reimburse pharmacies more for dispensing brand-name medicines to ...

The Danish drugmaker had said it aims to launch its blockbuster weight-loss drug, Wegovy, in India by 2026. The active ...

Basically, a brand-name drug company settles a patent infringement lawsuit by paying cash or transferring something else of ...

Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...

SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...